The proposed regulator would mirror existing sectoral authorities such as IRDAI for insurance, SEBI for capital markets, and ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

GlobeNewswire NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations GlobeNewswire Updated June 12, 2025 8:20 AM ...

While randomized controlled trials (RCTs) remain the gold standard in clinical research, integrating real-world evidence (RWE) through ECAs offers an opportunity to accelerate drug development and ...

As VCT has observed, research subjects don’t always stay in their lane, creating significant exposure to protocol violations, invalid endpoints, and regulatory risk. In fact, data from VCT show that 5 ...

US economic strategist and hedge fund manager Ronen Israel appointed Board Director, deepening North American investment connectivityAmrik Shah, ScD, joins as Chief Biometrics Officer, enhancing ...

Yaqrit has also appointed Amrik Shah as Chief Biometrics Officer. Amrik is a highly experienced biostatistician with 20+ years of experience in strategic design and analysis of clinical trials.

Yaqrit has also appointed Amrik Shah as Chief Biometrics Officer. Amrik is a highly experienced biostatistician with 20+ years of experience in strategic design and analysis of clinical trials. His ...

Press Releases CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India ACCESS Newswire April 29, 2025 9:01 AM ...